These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16468087)

  • 1. Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program.
    Hegwer G; Fairley C; Charrow J; Ormond KE
    J Genet Couns; 2006 Feb; 15(1):61-70. PubMed ID: 16468087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practices in synagogues regarding Jewish genetic disease education.
    Thomsen AJ; Matthews AL; Mitchell AL; Cohen L
    J Genet Couns; 2020 Dec; 29(6):1041-1049. PubMed ID: 32091143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge, attitudes, and barriers to carrier screening for the Ashkenazi Jewish panel: a Florida experience : Education and Barriers assessment for Jewish Genetic Diseases.
    Warsch JR; Warsch S; Herman E; Zakarin L; Schneider A; Hoffman J; Wasserman D; Barbouth D
    J Community Genet; 2014 Jul; 5(3):223-31. PubMed ID: 24415495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.
    Lehmann LS; Weeks JC; Klar N; Garber JE
    Genet Med; 2002; 4(5):346-52. PubMed ID: 12394347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women.
    Schwartz MD; Benkendorf J; Lerman C; Isaacs C; Ryan-Robertson A; Johnson L
    Cancer; 2001 Aug; 92(4):932-40. PubMed ID: 11550168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Tay-Sachs disease screening program.
    Gason AA; Sheffield E; Bankier A; Aitken MA; Metcalfe S; Barlow Stewart K; Delatycki MB
    Clin Genet; 2003 May; 63(5):386-92. PubMed ID: 12752571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a Carrier Screening Program in a High-Risk Undergraduate Student Population Using Digital Marketing, Online Education, and Telehealth.
    Hardy MW; Kener HJ; Grinzaid KA
    Public Health Genomics; 2018; 21(1-2):67-76. PubMed ID: 30408784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students.
    Barlow-Stewart K; Burnett L; Proos A; Howell V; Huq F; Lazarus R; Aizenberg H
    J Med Genet; 2003 Apr; 40(4):e45. PubMed ID: 12676918
    [No Abstract]   [Full Text] [Related]  

  • 10. Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women.
    Hardy MW; Peshkin BN; Rose E; Ladd MK; Binion S; Tynan M; McBride CM; Grinzaid KA; Schwartz MD
    J Community Genet; 2022 Jun; 13(3):281-292. PubMed ID: 35486291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients.
    Akler G; Birch AH; Schreiber-Agus N; Cai X; Cai G; Shi L; Yu C; Larmore AM; Mendiratta-Vij G; Elkhoury L; Dillon MW; Zhu J; Mclellan AS; Suer FE; Webb BD; Schadt EE; Kornreich R; Edelmann L
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1053. PubMed ID: 31880409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R; Pereira Lda V
    Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes of the general population towards preconception expanded carrier screening for autosomal recessive disorders including inborn errors of metabolism.
    Nijmeijer SCM; Conijn T; Lakeman P; Henneman L; Wijburg FA; Haverman L
    Mol Genet Metab; 2019 Jan; 126(1):14-22. PubMed ID: 30563741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools.
    Ioannou L; Massie J; Lewis S; Petrou V; Gason A; Metcalfe S; Aitken MA; Bankier A; Delatycki MB
    Clin Genet; 2010 Jul; 78(1):21-31. PubMed ID: 20597919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preconception expanded carrier screening: Impact of information presented by text or video on genetic knowledge and attitudes.
    Conijn T; Nijmeijer SCM; Lakeman P; Henneman L; Wijburg FA; Haverman L
    J Genet Couns; 2021 Apr; 30(2):457-469. PubMed ID: 32940388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis heterozygote screening in the Orthodox Community of Ashkenazi Jews: the Dor Yesharim approach and heterozygote frequency.
    Abeliovich D; Quint A; Weinberg N; Verchezon G; Lerer I; Ekstein J; Rubinstein E
    Eur J Hum Genet; 1996; 4(6):338-41. PubMed ID: 9043867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening.
    Grinzaid KA; Page PZ; Denton JJ; Ginsberg J
    J Genet Couns; 2015 Jun; 24(3):381-7. PubMed ID: 25502003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current attitudes and preconceptions towards expanded carrier screening in the Eastern Chinese reproductive-aged population.
    Zhang F; Tan J; Shao B; Jiang T; Zhou R; Wang Y; Zhang J; Qiao F; Ji X; Wang Y; Hu P; Xu Z
    J Assist Reprod Genet; 2021 Mar; 38(3):697-707. PubMed ID: 33409754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.